St Jude Wunderkind honored by STAT for work with synthesized organic molecules miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Protagonist Therapeutics (Nasdaq: PTGX) ("Protagonist" or "the Company") today reported financial results for the second quarter ended June 30,.
– BBI-02 is a potential first-in-class, oral DYRK1A inhibitor with strong preclinical validation and broad potential to treat debilitating autoimmune and.
/PRNewswire/ Shirley Codada, MD, FAAHPM, Chief Medical Officer of Haven, North Central Florida s legacy mission-driven provider of hospice and palliative.